Hana Pharm Co Ltd (293480) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.021x

Based on the latest financial reports, Hana Pharm Co Ltd (293480) has a cash flow conversion efficiency ratio of 0.021x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩6.91 Billion ≈ $4.68 Million USD) by net assets (₩331.75 Billion ≈ $224.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hana Pharm Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Hana Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Hana Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hana Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hana Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Hana Pharm Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Polytec Holding AG VI:PYT	0.182x
Devyser Diagnostics AB ST:DVYSR	0.034x
NEOWIZ HOLDINGS Corporation KQ:042420	0.056x
Dharmaj Crop Guard Limited NSE:DHARMAJ	0.001x
Canadian Net Real Estate Investment Trust V:NET-UN	0.020x
Amotech Co. Ltd KQ:052710	0.021x
CO2 Energy Transition Corp. Common Stock NASDAQ:NOEM	-0.002x
Amica S.A. WAR:AMC	-0.008x

Annual Cash Flow Conversion Efficiency for Hana Pharm Co Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Hana Pharm Co Ltd from 2016 to 2025. View Hana Pharm Co Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩313.41 Billion ≈ $212.39 Million	₩9.18 Billion ≈ $6.22 Million	0.029x	-64.22%
2024-12-31	₩309.18 Billion ≈ $209.52 Million	₩25.30 Billion ≈ $17.14 Million	0.082x	+23.60%
2023-12-31	₩277.98 Billion ≈ $188.39 Million	₩18.40 Billion ≈ $12.47 Million	0.066x	-42.46%
2022-12-31	₩268.40 Billion ≈ $181.89 Million	₩30.88 Billion ≈ $20.93 Million	0.115x	+12.98%
2021-12-31	₩251.90 Billion ≈ $170.71 Million	₩25.66 Billion ≈ $17.39 Million	0.102x	+51.91%
2020-12-31	₩232.38 Billion ≈ $157.48 Million	₩15.58 Billion ≈ $10.56 Million	0.067x	-53.43%
2019-12-31	₩220.33 Billion ≈ $149.32 Million	₩31.72 Billion ≈ $21.49 Million	0.144x	+7.17%
2018-12-31	₩205.39 Billion ≈ $139.19 Million	₩27.59 Billion ≈ $18.70 Million	0.134x	-56.98%
2017-12-31	₩81.30 Billion ≈ $55.09 Million	₩25.38 Billion ≈ $17.20 Million	0.312x	+38.97%
2016-12-31	₩55.48 Billion ≈ $37.60 Million	₩12.46 Billion ≈ $8.45 Million	0.225x	--

About Hana Pharm Co Ltd

KO:293480 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$98.97 Million

₩146.04 Billion KRW

Market Cap Rank

#19321 Global

#956 in Korea

Share Price

₩8240.00

Change (1 day)

-0.96%

52-Week Range

₩8240.00 - ₩12290.00

All Time High

₩26028.86